Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease.

ABSTRACT: Metabolic-associated Fatty Liver Disease is one of the outstanding challenges in gastroenterology. The increasing incidence of the disease is undoubtedly connected with the ongoing obesity pandemic. The lack of specific symptoms in the early phases and the grave complications of the disease require an active approach to prompt diagnosis and treatment. Therapeutic lifestyle changes should be introduced in a great majority of patients; but, in many cases, the adherence is not satisfactory. There is a great need for an effective pharmacological therapy for Metabolic-Associated Fatty Liver Disease, especially before the onset of steatohepatitis. Currently, there are no specific recommendations on the selection of drugs to treat liver steatosis and prevent patients from progression toward more

SUBMITTER: Boldys A 

PROVIDER: S-EPMC10608225 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature